We speculate that the discrepancy in the SNP data between the cell line and tumor tissue reflects that the line arose from a subclonal population of progenitor tumor cells, which acquired the necessary mutation (loss of p16) in order to survive but did not contain some of the other molecular changes in the bulk of the tumor. The gene discussed is CDKN2A; the disease is neoplasm.